Amgen

One Amgen Center Drive, Thousand Oaks, CA 91320

Public
Healthcare & Pharmaceuticals - Biotechnology
over $1B
over 10K
(805) 447-1000
(805) 447-1010
investor.relations@amgen.com


Amgen Inc. (Amgen) is a biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for illnesses. It focuses solely on human therapeutics and concentrates on medicines based on cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, inflammation and nephrology. In addition to the Company?s marketed products, it has product candidates in mid- to late-stage development in a range of therapeutic areas, including oncology, hematology, inflammation, bone health, nephrology, cardiovascular and general medicine, which includes neuroscience. On March 4, 2011, the Company acquired BioVex Group, Inc. On April 7, 2011, it acquired Laboratorio Quimico Farmaceutico Bergamo Ltda (Bergamo). In June 2012, the Company ... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Amgen?




2086 Contacts at this company
Mary Darling
Chief of Staff for EVP, R&D
Angela Ross
Corporate Affairs Manager
Ellen Nichols
Director HR
Willy Liou
Regulatory Affairs Sr. Manager
Hermineh Aghanian
Senior Manager GRAAS Operations ...
Julie Brown
Strategic Market Director-National ...
Matthew Danilowicz
Specialist, Manufacturing
Corinna Jacob
Corporate Affairs Senior Manager
Kimberly Burns
Senior Manager

Jul 30, 2018 02:06:09
THOUSAND OAKS, Calif., July 26, 2018 /PRNewswire/ -- As part of Amgen\'s (NASDAQ:AMGN) planned executive succession to address upcoming retirements, the Company announced transition plans for two of its executive [...]

Oct 6, 2017 21:36:50
CAMBRIDGE, Mass., Oct. 6, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and LabCentral today announced that the nomination process to submit proposals to receive an Amgen-sponsored LabCentral Golden [...]

Oct 3, 2017 20:43:42
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Oct. 3, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and CytomX Therapeutics, Inc., (NASDAQ: CTMX) today announced that the companies [...]

Sep 25, 2017 21:36:54
THOUSAND OAKS, Calif., Sept. 25, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today provided an update on Hurricane Maria\'s impact on the Company\'s manufacturing facilities in Puerto Rico. The safety of the [...]

Sep 11, 2017 20:49:13
THOUSAND OAKS, Calif., Sept. 11, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:45 a.m. GMT on Thursday, [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.